Smoking, Lung Cancer Stage, and Prognostic Factors—Findings from the National Lung Screening Trial

Junjia Zhu,Steven Branstetter,Philip Lazarus,Joshua E. Muscat

DOI: https://doi.org/10.3390/ijerph21040400

IF: 4.614

2024-03-27

International Journal of Environmental Research and Public Health

Abstract:Background: Low-dose computed tomography (LDCT) increases the early detection of lung cancer. Identifying modifiable behaviors that may affect tumor progression in LDCT-detected patients increases the likelihood of long-term survival and a good quality of life. Methods: We examined cigarette smoking behaviors on lung cancer stage, progression, and survival in 299 ever-smoking patients with low-dose CT-detected tumors from the National Lung Screening Trial. Univariate and multivariate Cox models were used to estimate the hazard ratio (HR) for smoking variables on survival time. Results: Current vs. former smokers and early morning smokers (≤5 min after waking, i.e., time to first cigarette (TTFC) ≤ 5 min) had more advanced-stage lung cancer. The adjusted HR for current vs. former smokers was 1.3 (95% confidence interval [CI] 0.911–1.98, p = 0.136) for overall survival (OS) and 1.3 (0.893–1.87, p = 0.1736) for progression-free survival (PFS). The univariate hazard ratios for TTFC ≤ 5 min vs. >5 min were 1.56 (1.1–2.2, p = 0.013) for OS and 1.53 (1.1–2.12, p = 0.01) for PFS. Among current smokers, the corresponding HRs for early TTFC were 1.78 (1.16–2.74, p = 0.0088) and 1.95 (1.29–2.95, p = 0.0016) for OS and PFS, respectively. In causal mediation analysis, the TTFC effect on survival time was mediated entirely through lung cancer stage. Conclusion: The current findings indicate smoking behaviors at diagnosis may affect lung cancer stage and prognosis.

public, environmental & occupational health,environmental sciences

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to explore the impact of smoking behaviors (such as smoking status, time to first cigarette, etc.) on the disease staging, progression, and survival rates of lung cancer patients detected by low-dose computed tomography (LDCT). Specifically, the researchers hope to understand the following aspects:

1. **Relationship between smoking behavior and lung cancer staging**: Is there a difference in lung cancer staging between current smokers and former smokers? Does early smoking (i.e., smoking within 5 minutes of waking) lead to more advanced lung cancer?
2. **Impact of smoking behavior on survival rates**: Does smoking behavior affect overall survival (OS) and progression-free survival (PFS) of patients?
3. **Mechanism of smoking behavior's impact on lung cancer progression**: How does smoking behavior indirectly affect patient survival by influencing lung cancer staging?

### Research Background

Most lung cancer patients are diagnosed at an advanced stage, with poor prognosis. Since 2004, data from the U.S. Surveillance, Epidemiology, and End Results (SEER) program show that about 70% of lung cancer patients are diagnosed at stage III or IV. Advanced disease is a major determinant of lung cancer progression and survival. Smoking behavior at the time of diagnosis may also affect disease progression. Previous studies have shown that patients who recently quit smoking have better survival rates than those who continue to smoke.

With the widespread use of low-dose CT screening, more early-stage lung cancer patients are being detected. Therefore, studying the impact of smoking behavior on these early-detected lung cancer patients is of great significance. This not only helps improve patient survival rates but also enhances their quality of life.

### Research Methods

The researchers used data from the National Lung Screening Trial (NLST) to analyze the smoking behaviors, disease staging, and survival data of 299 former smokers who were detected with lung cancer through low-dose CT. Using univariate and multivariate Cox proportional hazards models, the researchers estimated the impact of smoking behavior on survival time. Additionally, causal mediation analysis was conducted to explore the mechanism by which smoking behavior affects survival time through lung cancer staging.

### Main Findings

1. **Smoking status and lung cancer staging**:
- Current smokers had more advanced lung cancer compared to former smokers.
- Patients who smoked early (≤5 minutes) had more advanced lung cancer compared to those who smoked later (>5 minutes).

2. **Impact of smoking behavior on survival rates**:
- Univariate analysis showed that patients who smoked early (≤5 minutes) had significantly lower overall survival and progression-free survival compared to those who smoked later.
- In multivariate analysis, after adjusting for lung cancer staging and other confounding factors, the impact of smoking behavior on survival rates was no longer significant.

3. **Causal mediation analysis**:
- The impact of smoking behavior on survival time was fully mediated by lung cancer staging. This means that early smoking leads to more advanced lung cancer, which in turn affects survival time.

### Conclusion

The study results indicate that smoking behavior (especially early smoking) may indirectly affect patient survival by influencing lung cancer staging. These findings highlight the importance of identifying high-risk smokers in low-dose CT screening and support the inclusion of early smoking as an additional criterion for LDCT screening eligibility. Furthermore, the study suggests that changes in smoking behavior (such as quitting smoking) may help improve the prognosis of lung cancer patients.